Search research articles
Contact Us
Filters
Showing results (181-190 of 204) with videos related to
Page
of 21
Sort By:
The Journal of Urology
|
August 27, 2021
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
BJU International
|
November 5, 2020
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis
Francesco Soria, Peter C Black, Adrian S Fairey, et al.
Urologic Oncology
|
September 3, 2025
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study
Dimitra Rafailia Bakaloudi, Elizabeth L Koehne, Jenna M Voutsinas, et al.
Molecular Oncology
|
August 3, 2023
Pharmacological NF-κB inhibition decreases cisplatin chemoresistance in muscle-invasive bladder cancer and reduces cisplatin-induced toxicities
Rui M Gil da Costa, Christine Levesque, Daniella Bianchi-Frias, et al.
Cancer Research Communications
|
August 6, 2025
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
Hyun Jung Lee, Roman Gulati, Erolcan Sayar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 15, 2026
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology
Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024
Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Clinical Genitourinary Cancer
|
September 6, 2024
Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor
Dimitra Rafailia Bakaloudi, Rafee Talukder, Dimitrios Makrakis, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 18, 2023
The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy
Matthew D Ho, Anna J Black, Homayoun Zargar, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 204) with videos related to
Sort By:
Page
of 21
The Journal of Urology
|
August 27, 2021
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer
David D'Andrea, Peter C Black, Homayoun Zargar, et al.
BJU International
|
November 5, 2020
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis
Francesco Soria, Peter C Black, Adrian S Fairey, et al.
Urologic Oncology
|
September 3, 2025
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study
Dimitra Rafailia Bakaloudi, Elizabeth L Koehne, Jenna M Voutsinas, et al.
Molecular Oncology
|
August 3, 2023
Pharmacological NF-κB inhibition decreases cisplatin chemoresistance in muscle-invasive bladder cancer and reduces cisplatin-induced toxicities
Rui M Gil da Costa, Christine Levesque, Daniella Bianchi-Frias, et al.
Cancer Research Communications
|
August 6, 2025
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
Hyun Jung Lee, Roman Gulati, Erolcan Sayar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 15, 2026
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology
Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024
Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Clinical Genitourinary Cancer
|
September 6, 2024
Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor
Dimitra Rafailia Bakaloudi, Rafee Talukder, Dimitrios Makrakis, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 18, 2023
The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy
Matthew D Ho, Anna J Black, Homayoun Zargar, et al.
Page
of 21